72 related articles for article (PubMed ID: 22394008)
21. Interaction of cyclooxygenase 2 genotype and smoking habit in Taiwanese lung cancer patients.
Liu CJ; Hsia TC; Wang RF; Tsai CW; Chu CC; Hang LW; Wang CH; Lee HZ; Tsai RY; Bau DT
Anticancer Res; 2010 Apr; 30(4):1195-9. PubMed ID: 20530427
[TBL] [Abstract][Full Text] [Related]
22. [Cyclooxygenase-2 -765G>C polymorphism and susceptibility to colorectal cancer: a meta-analysis].
Chen X; Dong W; Wang J; Lyu X; Lei H; Liu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Jan; 48(1):62-6. PubMed ID: 24713293
[TBL] [Abstract][Full Text] [Related]
23. A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation.
Moore AE; Young LE; Dixon DA
Oncogene; 2012 Mar; 31(12):1592-8. PubMed ID: 21822307
[TBL] [Abstract][Full Text] [Related]
24. Lack of association of the cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphism with risk of cervical cancer in Korean population.
Lee TS; Jeon YT; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():134-42. PubMed ID: 17404026
[TBL] [Abstract][Full Text] [Related]
25. A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population.
Hu Z; Miao X; Ma H; Wang X; Tan W; Wei Q; Lin D; Shen H
Lung Cancer; 2005 Apr; 48(1):11-7. PubMed ID: 15777967
[TBL] [Abstract][Full Text] [Related]
26. The association between cyclooxygenase-2 (COX-2/PTGS2) gene polymorphism and osteoarthritis.
Güler VG; Yalın S; Berköz M; Cimen OB; Yalın E; Eroğlu P; Kanık A
Eklem Hastalik Cerrahisi; 2011; 22(1):22-7. PubMed ID: 21417982
[TBL] [Abstract][Full Text] [Related]
27. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
[TBL] [Abstract][Full Text] [Related]
28. Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis.
Feng YQ; Li YU; Xiao WD; Wang GX; Li YO
Genet Mol Res; 2015 Oct; 14(4):13391-402. PubMed ID: 26535654
[TBL] [Abstract][Full Text] [Related]
29. POLYMORPHISM OF THE COX-2 GENE AND SUSCEPTIBILITY TO COLON AND RECTAL CANCER.
Cossiolo DC; Costa HCM; Fernandes KBP; Laranjeira LLS; Fernandes MTP; Poli-Frederico RC
Arq Bras Cir Dig; 2017; 30(2):114-117. PubMed ID: 29257846
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the 3'UTR of the prostaglandin synthetase-2 (PTGS-2/COX-2) gene in non-melanoma skin cancer after organ transplantation.
Gomez-Lira M; Tessari G; Mazzola S; Malerba G; Rugiu C; Naldi L; Nacchia F; Valerio F; Anna B; Forni A; Boschiero L; Sandrini S; Faggian G; Girolomoni G; Turco A
Exp Dermatol; 2011 Dec; 20(12):1025-7. PubMed ID: 21995456
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer.
Yukawa T; Shimizu K; Maeda A; Yasuda K; Saisho S; Okita R; Nakata M
Oncol Rep; 2015 Jan; 33(1):74-80. PubMed ID: 25338928
[TBL] [Abstract][Full Text] [Related]
32. The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia.
Colaizzo D; Fofi L; Tiscia G; Guglielmi R; Cocomazzi N; Prencipe M; Margaglione M; Toni D
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):93-6. PubMed ID: 16479190
[TBL] [Abstract][Full Text] [Related]
33. Cox-2 polymorphisms and cardiovascular disease: elucidating the hidden side of the disease.
Cipollone F
Atherosclerosis; 2009 Dec; 207(2):348-9. PubMed ID: 19748096
[No Abstract] [Full Text] [Related]
34. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
[TBL] [Abstract][Full Text] [Related]
35. Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies.
Li Q; Liu L; Liu Y; Zhou H; Yang Z; Yuan K; Min W
Med Oncol; 2015 Jan; 32(1):397. PubMed ID: 25433948
[TBL] [Abstract][Full Text] [Related]
36. -765 G→C and -1195 A→G promoter variants of the cyclooxygenase-2 gene decrease the risk for preeclampsia.
Gurdol F; Cakmakoglu B; Dasdemir S; Isbilen E; Bekpinar S; Isbir T
Genet Test Mol Biomarkers; 2012 May; 16(5):435-8. PubMed ID: 22224631
[TBL] [Abstract][Full Text] [Related]
37. COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention.
Pereira C; Pimentel-Nunes P; Brandão C; Moreira-Dias L; Medeiros R; Dinis-Ribeiro M
Eur J Gastroenterol Hepatol; 2010 May; 22(5):607-13. PubMed ID: 20075740
[TBL] [Abstract][Full Text] [Related]
38. COX-2 polymorphisms -765G→C and -1195A→G and hepatocellular carcinoma risk.
Gharib AF; Karam RA; Abd El Rahman TM; Elsawy WH
Gene; 2014 Jun; 543(2):234-6. PubMed ID: 24720952
[TBL] [Abstract][Full Text] [Related]
39. COX2 and p53 risk-alleles coexist in COPD.
Arif E; Vibhuti A; Deepak D; Singh B; Siddiqui MS; Pasha MA
Clin Chim Acta; 2008 Nov; 397(1-2):48-50. PubMed ID: 18692035
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 polymorphisms and pancreatic cancer susceptibility.
Özhan G; Lochan R; Leathart JB; Charnley R; Daly AK
Pancreas; 2011 Nov; 40(8):1289-94. PubMed ID: 21705955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
